Zobrazeno 1 - 10
of 38
pro vyhledávání: '"GR Venning"'
Autor:
JR Shelton, LE Ramsay, GT McInnes, RM Perkins, JM Clarke, IR Harrison, Michael J Asbury, GR Venning
Publikováno v:
British journal of clinical pharmacology. 13(3)
1 The renal antimineralocorticoid potency of single doses of thirteen compounds with properties in animals compatible with competitive aldosterone antagonism was compared to that of spironolactone in healthy men. 2 Twelve compounds showed significant
Publikováno v:
British journal of clinical pharmacology. 4(1)
1. There seems no reason why clinical pharmacology studies conducted within the pharmaceutical industry should be exempt from the requirement of ethical review, and independent review in this situation reduces the vulnerability of the company and its
Publikováno v:
British Journal of Clinical Pharmacology. 9:295P-296P
Autor:
Venning GR
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 1998 Oct 10; Vol. 317 (7164), pp. 1011; author reply 1011-2.
Autor:
Venning GR
Publikováno v:
BMJ (Clinical research ed.) [BMJ] 1996 Sep 21; Vol. 313 (7059), pp. 751.
Autor:
Venning GR; Pharmaceutical Research Services Ltd, High Wycombe Bucks, England.
Publikováno v:
The Journal of the Association of Physicians of India [J Assoc Physicians India] 1993 Apr; Vol. 41 (4), pp. 214-6.
Autor:
Venning GR
Publikováno v:
The New England journal of medicine [N Engl J Med] 1992 Aug 13; Vol. 327 (7), pp. 502.
Autor:
Venning GR; Department of Microbiology, University College Hospital, London., Scott GM
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 1992 Mar; Vol. 33 (3), pp. 349-56.
Autor:
Venning GR
Publikováno v:
Medical toxicology and adverse drug experience [Med Toxicol Adverse Drug Exp] 1987 Jul-Aug; Vol. 2 (4), pp. 235-41.
Autor:
Venning GR
Publikováno v:
British medical journal (Clinical research ed.) [Br Med J (Clin Res Ed)] 1983 Feb 12; Vol. 286 (6364), pp. 544-7.